GobyMeds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.4/10
Best for: moving between compounded and brand without changing seller
What GobyMeds does best is charge less than most of the register.
then $99/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
GobyMeds is a low-cost telehealth seller. Compounded semaglutide is the only medication it offers.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to GobyMeds
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
GobyMeds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide
- Starting price
- $93/mo ($299 total for 12 weeks incl. medication, shipping, consultation, injection kit; JUMPSTART20 promo $279 total ($93/mo...)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How GobyMeds scores
Six columns, each one computed from something GobyMeds has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
10.0/10$133/month is 50% below the register median of $267 for compounded tirzepatide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
6.5/10does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
7.0/10The price covers medication, consult, shipping.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on GobyMeds
Last checked August 2026- Re-read the price on file across 10 dose or plan tiers
- Established what the monthly figure covers, and what it leaves out
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with GobyMeds involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1GobyMeds publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3GobyMeds does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- 4The monthly price is recorded as covering medication, consult, shipping.
- Cheapest standing monthly prices on record: semaglutide $99, tirzepatide $133. Membership fees, first-month rates and insured copays are excluded from those figures.
- No state list is published, so whether GobyMeds serves your state cannot be confirmed from its site.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
GobyMeds support, as documented
- Phone
- +1 866 785 9869
GLP-1 medications GobyMeds offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
$299 total for 12 weeks incl. medication, shipping, consultation, injection kit; JUMPSTART20 promo $279 total ($93/mo) — promo end-dated Dec 31 2025 but still displayed July 2026
$399 total / 12 weeks
$499 total / 12 weeks; JUMPSTART PROMO PRICE $439 ($146/month) shown under the higher-dose block
JUMPSTART20 promo $159
$399 total for 12 weeks incl. medication, shipping, consultation, injection kit; promo price shown unchanged at $399
$499 total / 12 weeks
$599 total / 12 weeks; JUMPSTART PROMO PRICE $479+ (price dependent on dose)
Primary pricing block says $299 (promo $279); a duplicated template block on the same page shows $349 — site inconsistency
Promo codes 'not valid on Zepbound and Wegovy'
Promo codes 'not valid on Zepbound and Wegovy'
Check the price yourself before you pay
Every figure here was read off GobyMeds's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- Tirzepatide at $133 a month, 50% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication, consult, shipping
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What GobyMeds charges
The figure GobyMeds leads with is $93, and it is a first-month rate. From month two the price is $99/month, which is the number to plan around. Nothing improper about an introductory offer — it just is not the price of staying on the medication.
- Compounded semaglutide — $93 first month, then $99/month
- Compounded semaglutide — $133/month
- Compounded semaglutide — $146 first month, then $166/month
- Compounded semaglutide — $159 first month, then $169/month
- Compounded tirzepatide — $133/month
- Compounded tirzepatide — $166/month
Across the GLP-1 providers in our register the median standing price is about $169/month, so GobyMeds is genuinely under the middle rather than merely advertising that it is.
TRYM Health dispenses semaglutide and tirzepatide from $96/month, which makes it the honest comparison to run before committing here.
What GobyMeds dispenses
GobyMeds prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. Both routes are available: the FDA-approved pen, or a compounded version at lower cost. The distinction is not cosmetic — the approved product has been reviewed for safety, efficacy and manufacturing quality, and a compounded preparation has not.
What we could verify
GobyMeds publishes little that can be checked from outside an intake. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will be paying in month three.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want a cheap way to find out whether the medication suits you before committing
Our read
GobyMeds is a cheap way to start and an ordinary way to continue. Use the $93 month for what it is good for — establishing whether the medication works for you — and re-run the numbers against $99/month before you let it renew twice.
The Bottom Line
What GobyMeds does best is charge less than most of the register.
Before you pay GobyMeds
Starting at $93/month. Check today's price, then book the free consultation.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this GobyMeds review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See GobyMeds's current pricing
Plans start at $93/month. The free consultation is where you learn whether you qualify, and what it costs today.